Skip to main content

Advanced Search

Projected result for your current search:: 0

Search Operators:

You can use operators in your search query to narrow down your results even more. Click on the search operator to see an explanation of how it works.
Finds documents with exactly this word group, in exactly this word order and spelling (e.g. "employer branding").
Finds documents with both search terms (e.g. sales AND bonus).
Finds documents with one or the other search term (e.g. porsche OR volkswagen).
Finds documents with all search terms. Blank space is understood as AND (e.g. man robot production).
Finds documents with no appearance of the word behind NOT (e.g. ford NOT "harrison ford").
Finds documents where the search term is mentioned at least "n" times."n" may be any number (e.g. COUNT(gear)>8).
Finds documents with both search terms in any word order, permitting "n" words as a maximum distance between them. Best choose between 15 and 30 (e.g. NEAR(recruit, professionals, 20)).
Finds documents with the search term in word versions or composites. The asterisk * marks whether you wish them BEFORE, BEHIND, or BEFORE and BEHIND the search term (e.g. lightweight*, *lightweight, *lightweight*).
Finds documents with the search term in different spellings. "?" allows only one character (e.g. organi?ation).
Special characters are understood as AND (e.g. Miller Bros. & Sons).
 Log in
Top

International Journal of Clinical Oncology

Issue 11/2025

Content (22 Articles)

PMDA regulatory update on approval and revision of the precautions for use of anticancer drugs in Japan; nivolumab plus ipilimumab for colorectal cancer, trastuzumab deruxtecan for breast cancer, and acalabrutinib for mantle cell lymphoma

Noriomi Matsumura, Masaki Mandai

First-line treatment options for metastatic urothelial carcinoma: balancing efficacy, safety, and individual values and preferences through shared decision making

Yoshiyuki Nagumo, Bryan J. Mathis, Hiroyuki Nishiyama

Policy recommendations for promoting nuclear medicine therapy in Japan 2025, from the Working Group for promoting nuclear medicine therapy of the Japan Society of Clinical Oncology

  • Open Access
  • Special Article

Kotaro Suzuki, Hideaki Miyake, Anri Inaki, Shoko Takano, Yasutoshi Kuboki, Takashi Mizowaki, Katsumasa Nakamura, Makoto Ueno, Shigemi Matsumoto, Daisuke Obinata, Tohru Nakagawa, Masato Murakami, Yoshiyuki Majima, Megumu Yokono, Masao Namba, Takayuki Yoshino

Relative survival among cancer survivors enrolled in private cancer insurance in Japan, using the internal insurance-enrolled population as the reference

Makoto Hiraoka, Hayaka Uekusa, Akira Okada, Reiko Inoue, Kayo Ikeda-Kurakawa, Yusuke Otsuka, Daisuke Namiki, Ryuichi Yamamoto, Toshimasa Yamauchi, Masaomi Nangaku, Kazuhiko Ohe, Satoko Yamaguchi, Takashi Kadowaki

Epidermal growth factor receptor inhibitor-related skin toxicities: a review of management and possible preventive and therapeutic approaches for Asian patients by the Japanese Pharmacist-led Oncodermatology Study Team

Yohei Iimura, Hirotoshi Iihara, Yoshitaka Saito, Hisanaga Nomura, Takuya Iwamoto, Mayumi Kotera, Yusuke Tsuchiya, Tatsuya Sumiya, Mariko Kono, Daisuke Hirate, Tomohiro Kurokawa, Toshinobu Hayashi, Hironobu Hashimoto, Junichi Higuchi, Ryuta Urakawa, Hiroyuki Saotome, Seiichiro Kuroda

Cognitive-behavioral and mindfulness-based therapies for mental health and quality of life of breast cancer patients: a meta-analysis of randomized controlled trials

Ruiyi Su, Ruixiang Wang, Zhuyi Li, Yunyun Wang, Xiaoye Zhao, Yihan Sun, Jingwei Ni, Yichun Zhu, Jie Luan, Guangyu Tian, Tian Tian

Comparative neurological safety of novel hormonal therapies in advanced prostate cancer: a Bayesian network meta-analysis of randomized trials

Ganesh Bushi, Aftab Ullah, Urooj Khan, Haiqa Sayyed, Muhammed Shabil

Speckled antinuclear antibody pattern as a potential predictor for immune-related adverse events in cancer patients

Hiroki Kohno, Masaaki Yanai, Miyu Nishigami, Shiro Moriyama, Genki Inui, Takafumi Nonaka, Yoshiki Hoshino, Yoshihiro Funaki, Takakazu Nagahara, Masahiro Kodani, Akira Yamasaki

Trends in the use of Japanese herbal Kampo medicine in inpatients with cancer: a 14-year nationwide analysis

Chikako Iwai, Takaaki Konishi, Shotaro Aso, Hiroki Matsui, Kiyohide Fushimi, Hideo Yasunaga

A single-center retrospective study of dabrafenib plus trametinib combination therapy in patients with BRAF V600E-positive thyroid cancer

Taiju Ando, Yuko Oya, Yumi Tomiie, Kimio Ogawa, Tomoki Kuki, Yosuke Tanabe, Hisayuki Kato, Kazuyoshi Imaizumi, Yatsuka Hibi, Kenji Kawada

Neutrophil-to-lymphocyte ratio affects the impact of proton pump inhibitors on efficacy of immune checkpoint inhibitors in patients with non‑small-cell lung cancer

Tomoki Hori, Kazuhiro Yamamoto, Takefumi Ito, Shigeki Ikushima, Tomohiro Omura, Ikuko Yano

Impact of antibiotic use on survival in patients with advanced non-small cell lung cancer treated with immune checkpoint inhibitor and chemotherapy

Nobuaki Ochi, Eiki Ichihara, Toshihide Yokoyama, Koji Inoue, Tomoki Tamura, Hiromi Watanabe, Ichiro Takata, Hirohisa Kano, Kayo Nakamura, Haruyuki Kawai, Masaaki Inoue, Nobukazu Fujimoto, Hirohisa Ichikawa, Chihiro Ando, Isao Oze, Nagio Takigawa, Yoshinobu Maeda, Katsuyuki Hotta

Music therapy preferences among breast cancer patients undergoing perioperative chemotherapy: from qualitative insight to quantitative evidence

Nanami Nakaya, Ami Yamasato, Mayu Kondo, Shigeki Okino, Atsuko Kitano, Banri Tsuda, Makoto Tokuhara, Kenji Yamamoto

Postoperative chemotherapy after conversion surgery for clinical stage IV gastric cancer: a propensity score-matched analysis

Yasunori Masuike, Takeshi Omori, Kazuyoshi Yamamoto, Yoshitomo Yanagimoto, Yuki Ushimaru, Kei Yamamoto, Takashi Kanemura, Takahito Sugase, Norihiro Matsuura, Ryota Mori, Masatoshi Kitakaze, Masahiko Kubo, Yasunari Fukuda, Hisateru Komatsu, Masaaki Miyo, Toshinori Sueda, Yoshinori Kagawa, Kunihito Goto, Shogo Kobayashi, Masayuki Ohue, Hiroshi Miyata

Efficacy and safety of talaporfin sodium photodynamic therapy as a salvage treatment for locally recurrent esophageal squamous cell carcinoma

Mamoru Tanaka, Makiko Sasaki, Hirotada Nishie, Yuki Kojima, Yasunari Sasaki, Taketo Suzuki, Shigeki Fukusada, Naomi Sugimura, Keiji Ozeki, Takaya Shimura, Eiji Kubota, Hiromi Kataoka

A phase II study evaluating the preventive effect of topical hydrocortisone for capecitabine-induced hand-foot syndrome in patients with colorectal cancer receiving adjuvant chemotherapy with capecitabine plus oxaliplatin (T-CRACC study)

Yohei Iimura, Keisuke Baba, Naoki Furukawa, Masaaki Ishibashi, Chieko Sasuga, Yuka Ahiko, Satoko Monma, Naoki Sakuyama, Susumu Aikou, Dai Shida, Masanori Nojima, Seiichiro Kuroda, Narikazu Boku

Socioeconomic disparities in colorectal cancer oncologic emergencies: a nationwide multilevel analysis in Japan

Mariko Hanafusa, Nobutoshi Nawa, Masato Ota, Tomoki Nakaya, Yasuhito Fujisaka, Kiyohide Fushimi, Takeo Fujiwara, Yuri Ito

Predictors of early progressive disease and antitumor effects by metastatic site in renal cell carcinoma treated with ipilimumab plus nivolumab

Keiichiro Mori, Takafumi Yanagisawa, Tatsushi Kawada, Satoshi Katayama, Ryoichi Maenosono, Takuya Tsujino, Takeshi Hashimoto, Yosuke Hirasawa, Lan Inoki, Shingo Toyoda, Takuhisa Nukaya, Kiyoshi Takahara, Wataru Fukuokaya, Fumihiko Urabe, Takehiro Iwata, Kensuke Bekku, Yoshio Ohno, Ryoichi Shiroki, Kazutoshi Fujita, Haruhito Azuma, Motoo Araki, Takahiro Kimura

Prognostic factors of lenvatinib plus pembrolizumab therapy for advanced or recurrent endometrial cancer: analysis of a multicenter cohort study in Japan

Yoshikazu Nagase, Satoshi Nakagawa, Mariya Kobayashi, Hiroki Kurahashi, Hiromi Ogimoto, Ayaka Tanaka, Tomoko Tsujie, Mayu Shiomi, Akiko Otake, Kanji Masuhara, Kenichi Yoshikawa, Fusanori Yotsumoto, Tomoko Kurita, Kiyoshi Yoshino, Emi Yoshioka, Tomomi Egawa-Takata, Wataru Kudaka, Masayuki Sekine, Hikari Unno, Masahiko Takemura, Saki Aso, Kentaro Kai, Eiji Kobayashi, Takeshi Yokoi, Masashi Akada, Reisa Kakubari, Tsuyoshi Hisa, Shinya Matsuzaki, Yutaka Ueda

Long-term outcomes of venetoclax and ibrutinib in Japanese patients with relapsed/refractory mantle cell lymphoma

Hideki Goto, Satoshi Ito, Masahiro Kizaki, Masaki Yamaguchi, Noriko Fukuhara, Koji Kato, Toko Saito, Yasuhito Terui, Tomomi Soshin, Natsuko Satomi-Tsushita, Hideyuki Honda, Chen Qian, Koji Izutsu

Efficacy and safety of mycophenolate mofetil in patients with high-grade locally advanced or metastatic osteosarcoma (ESMMO): a multicenter, phase II clinical trial

Nut Koonrungsesomboon, Pimpisa Teeyakasem, Nahathai Dukaew, Nutnicha Sirikaew, Patcharawadee Thongkumkoon, Petlada Yongpitakwattana, Viraporn Thepbundit, Parunya Chaiyawat, Jeerawan Klangjorhor, Chotiwit Sakuludomkan, Chaiyut Charoentum, Busyamas Chewaskuyong, Lalita Sathitsamitphong, Piya Kiatisevi, Patrapim Sunpaweravong, Chirawadee Sathitruangsak, Dumnoensun Pruksakorn

Longitudinal nationwide analysis of uveal melanoma in the United States 1995–2018

Ahmad Samir Alfaar, Mohamed H. Abdel-Rahman, Moataz Hamed Osman

Oct 25
Issue: 10/2025
Including Invited Reviews on Significance of BRCA genetic test for breast cancer
Dec 25
Issue: 12/2025

Latest issues

scroll for more

use your arrow keys for more

scroll or use arrow keys for more

Case simulations: Biomarker-driven management of NSCLC (Link opens in a new window)

Do you want to assess your biomarker testing skills and management decisions? Use these simulation-based case studies based on realistic NSCLC scenarios to do so in a practical and secure environment.

Independent Medical Education Grant:
  • Bayer HealthCare Pharmaceuticals Inc.
Learn more Link opens in a new window
COMMISSIONED

How-to guide for healthcare professionals: understanding genomic reports

This educational activity was initiated, funded and co-developed by Boehringer Ingelheim and is intended for healthcare professionals in the UK and Ireland only. 

Genomic testing helps inform cancer diagnosis, prognosis, and treatment. A genomic report is generated by the laboratory carrying out next-generation sequencing to analyze biopsy samples. Access this educational microsite to learn more about typical genomic report content and how to interpret test results for patients with cancer.

NP-GB-106631 | Jan 2026

Commissioned by:
  • Boehringer Ingelheim
Learn more
Image Credits
Biomarker-driven management of NSCLC logo/© Springer Health+ IME, DNA double helix structure on a purple background/© 2025 Adobe